Enzo Clinical Labs, INC.

Enzo Clinical Labs, INC. was paid $3.84M by Medicaid between Sep 2020 and Jul 2023, across 52 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 47% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Connecticut

Rank by total paid#8 of 27

Median peer was paid$561K

This provider vs. median6.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	15,500	$989K
2021	46,716	$1.73M
2022	24,517	$848K
2023	9,438	$280K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	47%	23,085	19,871	$1.81M
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	12%	2,920	2,777	$443K
87481		11%	2,873	2,745	$437K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	6.0%	9,986	9,027	$231K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	4.7%	5,848	5,524	$182K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	4.7%	5,828	5,508	$181K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	4.2%	5,663	5,223	$160K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	1.6%	2,925	2,807	$60K
87086	Culture, bacterial; quantitative colony count, urine	<1%	5,311	5,015	$35K
86803		<1%	2,881	2,755	$35K
86696		<1%	1,488	1,360	$31K
86706		<1%	2,926	2,784	$27K

40 more codes

87340		<1%	2,965	$26K
86480		<1%	477	$26K
87070		<1%	3,876	$25K
87186		<1%	2,812	$21K
86695		<1%	1,486	$21K
86780		<1%	1,178	$14K
87631		<1%	101	$10K
80053	Comprehensive metabolic panel	<1%	919	$8K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	1,205	$8K
86592		<1%	1,798	$7K
87088		<1%	848	$6K
87077		<1%	630	$5K
86762		<1%	366	$5K
84443	Thyroid stimulating hormone (TSH)	<1%	314	$5K
86765		<1%	379	$4K
86787		<1%	347	$4K
86735		<1%	351	$4K
87147		<1%	858	$4K
87184		<1%	500	$3K
87081		<1%	482	$3K
86769		<1%	68	$2K
87075		<1%	165	$2K
86618		<1%	52	$1K
86666		<1%	31	$1K
83036	Hemoglobin; glycosylated (A1C)	<1%	71	$602.55
84520		<1%	158	$535.53
82947		<1%	158	$532.50
82565		<1%	158	$339.25
85610		<1%	13	$41.36
84460		<1%	149	$5.05
84075		<1%	148	$4.94
82040		<1%	146	$4.35
82247		<1%	148	$2.86
84295		<1%	158	$1.43
82435		0%	158	$0.00
84132		0%	158	$0.00
82374		0%	157	$0.00
84450		0%	148	$0.00
82310		0%	156	$0.00
84155		0%	145	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWAGNER, ANN (REVENUE CYCLE DIRECTOR)

Parent organizationENZO BIOCHEM INC.